Publication|Articles|December 18, 2024
- Pharmaceutical Executive: December 2024
- Volume 44
- Issue 12
Pharmaceutical Executive: December 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
Trending Forwardabout 1 year ago
Pharma’s ‘Best-Kept Secret’about 1 year ago
Seeking More Value, Less Costabout 1 year ago
Dealmaking Dormant No Moreabout 1 year ago
A Rocky Road for Regulationabout 1 year ago
DTC's New Era of Engagementabout 1 year ago
Holding On Tight to AI Waveabout 1 year ago
The Recipe for Relief: Overcoming Industry Pain Pointsabout 1 year ago
Pharma Forecasting: Key Markets Investors Can’t Ignoreabout 1 year ago
Introducing Agentic AI: Its Revolutionary Potential in PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5